Response to Gupta et al., “Ultralow-Dose Rituximab in Pemphigus: Clinical Efficacy or Immunologic Underdosing”

Published: 5 August 2025| Version 1 | DOI: 10.17632/3dw58h98pz.1
Contributors:
Shan Cao, Tingting Liu, Wenchao Li, Zhenzhen Wang, Hong Liu, Furen Zhang

Description

Supplemental material for "Response to Gupta et al., “Ultralow-Dose Rituximab in Pemphigus: Clinical Efficacy or Immunologic Underdosing”"

Files

Institutions

  • Shandong Provincial Institute of Dermatology and Venereology

Categories

Rituximab, Pemphigus

Licence